Skip to content

Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments

Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments Using a CAD/CAM Technique: Randomized Controlled Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06455436
Enrollment
32
Registered
2024-06-12
Start date
2024-05-08
Completion date
2026-07-15
Last updated
2024-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Immediate Dental Implant, Wound Heal

Keywords

implant, soft tissue

Brief summary

The loss of a tooth leads to a series of biological changes in the tissues, resulting in bone resorption and gingival collapse. To avoid these problems, it has been proposed to place immediate post-extraction implants, allowing a reduction in treatment time and the number of surgeries, as well as better maintenance of the tissues. This technique can be performed with standard abutments after implant placement or, more recently, the use of temporary abutments has been proposed.

Detailed description

Objective: To check if custom healing abutments manufactured using CAD/CAM technique in immediate implants promote greater dimensional stability of the peri-implant tissue compared to standard healing abutments. Methods: After the extraction, an immediate Klockner Vega+ implant will be placed and the gap will be filled with a bone substitute (Cerabone, Botiss). The patient will then be randomized to the control group (standard healing abutment) or the test group (custom healing abutment using CAD/CAM technique). In the latter case, a peripheral seal is achieved, allowing for wound closure and stabilization of the clot with the same shape as the crown in its transmucosal part.

Interventions

Participants will undergo a surgery to place an immediate klockner dental implant and will be receive a standard healing abutment

DEVICEIndividualized healing abutment

Participants will undergo a surgery to place an immediate klockner dental implant and will be receive an individualized healing abutment

Sponsors

Universitat Internacional de Catalunya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patient ( 25 years old). * Need for extraction of an irrational tooth to be treated in the molar/premolar position of the upper/lower arch. * Presence of 2mm of keratinized gingiva. * Bone dehiscence in the alveolar walls of 2 mm. 2 mm. * Adequate amount of bone in the interradicular septum to stabilize the implant (minimum height 10 mm, minimum width 4 mm at the base of the septum). * Plaque index (FMSPI, full mouth score plaque index) \< 10%. * Non-smokers or smokers of less than 10 cigarettes per day. * Absence of systemic diseases that contraindicate implant surgery.

Exclusion criteria

* Presence of alveoli with dehiscence \>2mm. * Presence of adjacent implants. * \< 2mm of keratinized gingiva. * Presence of active infection (fistula, suppuration) at the extraction site. * Presence of apical granuloma \>2mm in diameter in the root(s) of the tooth or teeth to be extracted. * Residual bone apical to the extraction insufficient to anchor the implant. * Pregnant or lactating women. * Severe cognitive or psychiatric disorders. * Compromised general health status ( ASA IV). * Use of drugs that alter bone metabolism and healing. * Absence of manual primary stability of the implant * Bone dehiscence or fenestration after implant placement (manual rotation). * Gap 2mm between the implant and the vestibular bone wall.

Design outcomes

Primary

MeasureTime frameDescription
Buccal-lingual/palatal soft tissue dimensional changes12 monthsThey will be evaluated after superimposing the initial STL files with the follow-up ones. In addition, photos, periapical radiographs and a new intraoral scan at 3 months, 6 months and 1 year will be taken. In a 2D buccal-lingual slice corresponding to the center of the ridge, measure at the vestibular and palatal level from the point of maximum preoperative STL soft tissue contour (mucosal margin and at 3 mm and 5 mm apical to the margin).

Secondary

MeasureTime frameDescription
Vestibulo-lingual/palatal dimensional changes of the alveolar bone (CBCT)12 monthsTo measure dimensional changes in the alveolar bone, you can use cone-beam computed tomography (CBCT) scans. Compare CBCT images taken at different time points to quantify any changes in bone dimensions. measure dimensional changes in the alveolar bone, you can use cone-beam computed tomography (CBCT) scans. Compare CBCT images taken at different time points to quantify any changes in bone dimensions.
Horizontal remodeling of vestibular and lingual/palatal cortex (CBCT)12 monthsCBCT scans can also be used to assess horizontal remodeling of the cortical bone. Analyze the CBCT images to measure changes in cortical thickness or contour.
Thickness of vestibular and lingual/palatal cortex (CBCT)12 monthsCBCT scans can provide measurements of cortical thickness in the vestibular and lingual/palatal regions of the alveolar bone.
Vertical changes of the vestibular and lingual/palatine cortex (CBCT)12 monthsUse CBCT scans to measure any vertical changes in the vestibular and lingual/palatal cortical bone regions.
Dehiscence of peri-implant vestibular and lingual/palatal mucosa:12 monthsDehiscence can be assessed by carefully examining the peri- implant mucosa for any signs of tissue separation or exposure. This can be done visually during clinical examination.
Probing pocket depth12 monthsProbing pocket depth can be measured using periodontal probes. Insert the probe gently into the peri-implant sulcus and measure the distance from the mucosal margin to the implant-abutment interface.
Bleeding/Suppuration on probing12 monthsAssess bleeding or suppuration during probing. Note if there is any bleeding or exudate from the peri-implant sulcus when probing the tissues.
Implant survival12 monthsImplant survival can be determined by assessing whether the implant remains in place and functional over the study period. Any implant removals or failures should be documented.
Patient-reported variables (satisfaction, pain)12 monthsSubjective assessment of pain intensity and patient satisfaction using a 10-cm visual analog scale. The extremes of the scale are the extreme expressions of pain and discomfort (i.e., no pain and the worst imaginable pain) * Type of variable (units): scale (mm). * Time of registration: Appointment 4 (surgery), Appointment 5 (follow-up), Appointment 10 (End of study)
Marginal bone level (periapical x-ray)12 monthsPeriapical X-rays are commonly used to assess marginal bone levels around dental implants. Measure the distance from the implant-abutment interface to the crestal bone on these radiographs.

Countries

Spain

Contacts

Primary ContactJavi Vilarrasa, MSc
jvilarrasa@uic.es+34 628553000
Backup ContactNicolas Padros, DDs
nico.padros@uic.es+34 628289185

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026